Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake

被引:4
|
作者
Huff, Courtney [1 ]
Bhide, Nirmal [1 ]
Schroering, Allen [2 ]
Yamamoto, Bryan K. [2 ]
Gudelsky, Gary A. [1 ]
机构
[1] Univ Cincinnati, James Winkle Coll Pharm, Cincinnati, OH 45221 USA
[2] Univ Toledo, Coll Med, Dept Neurosci, Toledo, OH 43606 USA
关键词
MDMA; Serotonin; Serotonin transporter; CELL-SURFACE EXPRESSION; RAT-BRAIN; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; SEROTONIN TRANSPORTER; NITRIC-OXIDE; NEUROTOXICITY; DEPLETION; ECSTASY; PROTEIN; METHYLENEDIOXYMETHAMPHETAMINE;
D O I
10.1016/j.brainresbull.2013.01.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent studies have demonstrated that a preconditioning regimen (i.e., repeated low doses) of MDMA provides protection against the reductions in tissue concentrations of 5-HT and 5-HT transporter (SERT) density and/or expression produced by a subsequent binge regimen of MDMA. In the present study, the effects of preconditioning and binge treatment regimens of MDMA on SERT function were assessed by synaptosomal 5-HT uptake. Synaptosomal 5-HT uptake was reduced by 72% 7 days following the binge regimen (10 mg/kg, i.p. every 2 h for a total of 4 injections). In rats exposed to the preconditioning regimen of MDMA (daily treatment with 10 mg/kg for 4 days), the reduction in synaptosomal 5-HT uptake induced by a subsequent binge regimen was significantly less. Treatment with the preconditioning regimen alone resulted in a transient 46% reduction in 5-HT uptake that was evident 1 day, but not 7 days, following the last injection of MDMA. Furthermore, the preconditioning regimen of MDMA did not alter tissue concentrations of 5-HT, whereas the binge regimen of MDMA resulted in a long-term reduction of 40% of tissue 5-HT concentrations. The distribution of SERT immunoreactivity (ir) in membrane and endosomal fractions of the hippocampus also was evaluated following the preconditioning regimen of MDMA. There was no significant difference in the relative distribution of SERTir between these two compartments in control and preconditioned rats. The results demonstrate that SERT function is transiently reduced in response to a preconditioning regimen of MDMA, while long-term reductions in SERT function occur in response to a binge regimen of MDMA. Moreover, a preconditioning regimen of MDMA provides protection against the long-term reductions in SERT function evoked by a subsequent binge regimen of the drug. It is tempting to speculate that the neuroprotective effect of MDMA preconditioning results from a transient down-regulation in SERT function. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 50 条
  • [41] Platelet 5-HT transporter in pathological gamblers
    Golia, F.
    Marazziti, D.
    Baroni, S.
    Picchetti, M.
    Lenzi, F.
    Consoli, G.
    Carlini, M.
    Baldini, A.
    Giannaccini, G.
    Dell'Osso, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S566 - S567
  • [42] Characterization of the 5-HT transporter in human lymphocytes
    Marazziti, D
    Rossi, A
    Palego, L
    Giannaccini, G
    Lucacchini, A
    Cassano, GB
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 168 - 168
  • [43] RECOGNITION OF 5-HT TRANSPORTER BY ANTIPEPTIDE ANTIBODIES
    LAWRENCE, JA
    CHARTERS, AR
    BUTCHER, SP
    KELLY, JS
    OLVERMAN, HJ
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (03) : S473 - S473
  • [44] Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission
    Blier, P
    Piñeyro, G
    El Mansari, M
    Bergeron, R
    De Montigny, C
    ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 : 204 - 216
  • [45] Electrophysiological analysis of gating at the 5-HT transporter
    Mager, S
    Lester, H
    Cao, YW
    BIOPHYSICAL JOURNAL, 1998, 74 (02) : A252 - A252
  • [46] EFFECT OF SEROTONIN 5-HT(1), 5-HT(2), AND 5-HT(3) RECEPTOR ANTAGONISTS ON THE PROLACTIN RESPONSE TO RESTRAINT AND ETHER STRESS
    JORGENSEN, H
    KNIGGE, U
    WARBERG, J
    NEUROENDOCRINOLOGY, 1992, 56 (03) : 371 - 377
  • [47] 5-HT transporter gene polymorphism and depression
    Ogilvie, AD
    Battersby, S
    Smith, CAD
    Blackwood, DHR
    Muir, WJ
    Goodwin, GM
    Ebmeier, KP
    Harmar, AJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 : U160 - U160
  • [48] 5-HT ANTAGONISM ON CEREBRAL AND COMMON CAROTID ARTERIES BY THE 5-HT UPTAKE INHIBITORS FEMOXETINE AND PAROXETINE
    PETERSEN, EN
    EDVINSSON, L
    HARDEBO, JE
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1979, 45 (04): : 296 - 301
  • [49] EFFECTS OF TRANYLCYPROMINE ON 5-HT UPTAKE AND ITS INTERACTION WITH PCPA ON RAT-BRAIN 5-HT
    FRIEDMAN, E
    SHOPSIN, B
    GERSHON, S
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1976, 15 (01): : 191 - 194
  • [50] Endogenous 5-HT outflow from chicken aorta by 5-HT uptake inhibitors and amphetamine derivatives
    Delgermurun, Dugar
    Ito, Shigeo
    Ohta, Toshio
    Yamaguchi, Soichiro
    Otsuguro, Ken-ichi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2016, 78 (01): : 71 - 76